About
Rommel Fernandez
More than 20 years in pharma and biotech across multiple commercial roles, and the founder of RF Consulting.

Rommel Fernandez founded RF Consulting to advise companies preparing for or executing a U.S. launch.
Most recently he was Vice President, Corporate Strategy and Operations at Alpha Cognition (Nasdaq: ACOG), where he led U.S. commercial operations through the company’s Alzheimer’s disease launch. His remit covered commercial analytics, market access, incentive compensation, and the company’s AI roadmap.
Before that he was Chief Analytics Officer at Fingerpaint Group and Senior Director, Commercial Insights at La Jolla Pharmaceutical. Earlier roles were at Orexigen Therapeutics, Mallinckrodt (formerly Cadence Pharmaceuticals), and Amylin Pharmaceuticals.
His work sits where commercial strategy meets operations: the payer and gross-to-net assumptions behind a forecast, the incentive plan that shapes field behavior, and the data infrastructure a lean commercial team depends on. He has worked across CNS and Alzheimer’s disease, critical care, diabetes, obesity, and biosimilar oncology.
He runs RF Consulting with AI built into the work, including open-source models for material nonpublic information, on his own encrypted hardware or through zero-retention hosts. He developed the RF Launch Operating Model Framework, the method behind the launch engagement.
Rommel is based in San Diego, California, and is open to conversations about executive and board roles.
Areas of depth
- U.S. launch strategy
- Market access
- Gross-to-net
- Incentive compensation
- Omnichannel commercialization
- Commercial analytics
- Master data management and data warehousing
- Tableau and data visualization
- CRM systems
- Applied AI and secure LLM environments
Get in touch
For consulting engagements, advisory roles, or executive opportunities.